1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
(
- Contribution to journal › Article
-
Mark
Regulatory interplay between mir-181a-5p and estrogen receptor signaling cascade in breast cancer
(
- Contribution to journal › Article
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
(
- Contribution to journal › Article
- 2020
-
Mark
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors : a Danish population-based cohort study
(
- Contribution to journal › Article
- 2018
-
Mark
Statins : a role in breast cancer therapy?
(
- Contribution to journal › Scientific review
-
Mark
Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe
(
- Contribution to journal › Article
- 2011
-
Mark
Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial
(
- Contribution to journal › Article
- 2008
-
Mark
Life Style, Molecular Pathology, and Breast Cancer Risk
(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)
(
- Contribution to journal › Article
- 2003
-
Mark
An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole
(
- Contribution to journal › Article